Allezoe Medical Holdings, Inc.
OTC Bulletin Board : ALZM

July 08, 2011 15:00 ET

Allezoe Medical Holdings (ALZM) Board of Directors Elects New CEO

BOCA RATON, FLORIDA--(Marketwire - July 8, 2011) - Allezoe Medical Holdings, Inc. (OTCBB:ALZM) today announces that at a meeting of the Board of Directors held on July 6, 2011, Michael Holder resigned as Chief Executive Officer of Allezoe so that he could devote his full attention to the development of the Organ Transport Systems' LifeCradle® technology. Michael Gelmon, Chairman of the Board of Directors, was then unanimously elected to assume the position of President and CEO of Allezoe. Mr. Holder will remain as a director of Allezoe and as Chairman and CEO of Organ Transport Systems, Inc. ("OTS"), the wholly-owned subsidiary of Allezoe.

Allezoe Medical Holdings ("Allezoe") recently expanded its Board of Directors to include three additional members, including Mr. Gelmon. He was elected, again by unanimous vote, to Chairman of the Board of Allezoe in June 2011. In addition to his wide experience leading publicly traded companies as Director or CEO, Mr. Gelmon was the founding shareholder, Director, and Head of Acquisitions and Real Estate for Domino's Pizza of Canada, Ltd.

As Allezoe's new Chairman and CEO, Mr. Gelmon will oversee execution of Allezoe's business strategy. Allezoe has announced its intention to explore targeted opportunities for acquisition of medical device companies. Organ Transport Systems ("OTS") is currently Allezoe's sole subsidiary. OTS has developed technology to offer better preservation options for human organ transportation through its LifeCradle® product line. The company recently announced that it was in preparations for clinical trials and will be prioritizing the applications of its technology to donor heart preservation.

In addition to the appointment of Mr. Gelmon as CEO, Allezoe's Board of Directors also established committees of the Board of Directors, and appointed members of those committees. The Board also established independence standards for Committee membership, and determined that the Audit Committee and the Compensation Committee should be made up only of independent members, and that the Governance and Nominating Committee should be made up of a majority of independent members. Additionally, the Board adopted an Audit Committee Charter to guide the Audit Committee in its responsibilities and adopted Guidelines for Corporate Governance.

For more information please visit


This announcement is not an offer to sell any Allezoe ("ALZM") related securities. Offers for any given security are made only through applicable offering circulars and related documents filed with the SEC pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934. Certain statements contained herein and subsequent oral statements made by and on behalf of ALZM may contain "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements are identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and includes, without limitation, statements regarding ALZM's plan of business operations, product research and development activities, anticipated revenues and expenses and potential contractual arrangements and obligations. Also, our management may make forward-looking statements orally to investors, analysts, the media and others. Any statements made in this news release about an action, event or development, are forward-looking statements. Such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company. These risks and others are included from time to time in documents we file with the Securities and Exchange Commission, including but not limited to, its Form 10-Ks, Form 10-Qs and Form 8-Ks. Other unknown or unpredictable factors also could have material adverse effects on our future results. Accordingly, you should not place undue reliance on these forward-looking statements. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made as of the date hereof. The Company takes no obligation to update or correct its own forward-looking statements, except as required by law or those prepared by third parties that are not paid by the Company. The Company's SEC filings are available at

Contact Information